v3.26.3
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Operating activities        
Net increase (decrease) in net assets resulting from operations   $ 698,766 $ 9,953,442  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:        
Net realized (gain) loss   5,854,489 18,997,630  
Change in net unrealized (appreciation)/depreciation of investments   7,120,334 (11,310,099)  
Net amortization of investment discounts and premiums   (678,735) (1,309,055)  
Amortization of deferred debt issuance costs   405 405  
Interest and dividend income paid in kind   (1,113,472) (1,681,390)  
Changes in assets and liabilities:        
Purchases of investments   (8,752,561) (52,954,050)  
Proceeds from disposition of investments   37,429,957 47,281,664 $ 60,564,846
Decrease (increase) in interest receivable   859,500 (123,354)  
Decrease (increase) in receivable for investments sold   2,789,621 1,546,546  
Decrease (increase) in prepaid expenses and other assets   (2,733,089) 62,616  
Increase (decrease) in management fees payable   (89,587) (28,750)  
Increase (decrease) in reimbursements due to the Advisor   71,577 45,670  
Increase (decrease) in interest and debt related payables   3,300 3,300  
Increase (decrease) in payable for investments purchased   0 (99,494)  
Increase (decrease) in incentive fees payable   0 (883,149)  
Increase (decrease) in accrued expenses and other liabilities   239,488 168,224  
Net cash provided by (used in) operating activities   41,699,993 9,670,156  
Financing activities        
Proceeds from shares of common stock sold   0 20,066,666  
Distributions to shareholders $ (35,000,000) (44,292,010) (11,605,318)  
Net cash provided by (used in) financing activities   (44,292,010) 8,461,348  
Net increase (decrease) in cash and cash equivalents (including restricted cash)   (2,592,017) 18,131,503  
Cash and cash equivalents (including restricted cash) at beginning of period $ 47,184,002 47,184,002 28,380,210 28,380,210
Cash and cash equivalents (including restricted cash) at end of period   44,591,985 46,511,713 $ 47,184,002
Supplemental cash flow information        
Interest payments   $ 6,600 $ 6,600